Volatile Week, but Green? Click to watch the new Podcast.

$3.07 (-4.66%)

Volume: 20.208k

Closed: Jul 05, 2022

Hollow Logo Score: 1.589

Evoke Pharma Stock Forecast

BUY SELL NASDAQ:EVOK
$3.07 (-4.66%)

Volume: 20.208k

Closed: Jul 05, 2022

Score Hollow Logo 1.589

Evoke Pharma Company Profile

505 Lomas Santa Fe Drive

Solana Beach CA 92075

858-345-1494

www.evokepharma.com

Industry: Drug Manufacturers

Sector: Healthcare

Evoke Pharma

Description

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. The company develops EVK-001, a metoclopramide nasal spray, which is in Phase III clinical trials for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Evoke Pharma, Inc. was founded in 2007 and is headquartered in Solana Beach, California.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE